Healthcare Of Ontario Pension Plan Trust Fund Akero Therapeutics, Inc. Transaction History

Healthcare Of Ontario Pension Plan Trust Fund

$33.9 Billion
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 21, 2024	BUY	$11.38 - $50.33 $477,960 - $2.11 Million	42,000 Added 350.0%	54,000 $1.26 Million
Q3 2023 Nov 13, 2023	BUY	$41.19 - $52.25 $494,280 - $627,000	12,000 New	12,000 $606,000
Q4 2022 Feb 13, 2023	BUY	$33.44 - $54.8 $7.82 Million - $12.8 Million	234,000 New	234,000 $12.8 Million

Others Institutions Holding AKRO

# of Institutions

170

Shares Held

72.7M

Call Options Held

178K

Put Options Held

164K

Janus Henderson Group PLC London, X0

6.88M
Shares

$204 Million
0.09% of portfolio
Black Rock Inc. New York, NY

5.59M
Shares

$166 Million
0.0% of portfolio
Rtw Investments, LP New York, NY

5.43M
Shares

$161 Million
2.13% of portfolio
General Atlantic LLC New York, NY

5.23M
Shares

$156 Million
3.88% of portfolio
Wellington Management Group LLP Boston, MA

5.11M
Shares

$152 Million
0.02% of portfolio

View Full List

About Akero Therapeutics, Inc.

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.38B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

More about AKRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Healthcare Of Ontario Pension Plan Trust Fund, based on Form 13F filings with the SEC.

News

Stay updated on Healthcare Of Ontario Pension Plan Trust Fund with notifications on news.

Account